S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
These are the Top 4 Stocks for Buybacks in 2024
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
These are the Top 4 Stocks for Buybacks in 2024
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
These are the Top 4 Stocks for Buybacks in 2024
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
These are the Top 4 Stocks for Buybacks in 2024
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China

Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Aethlon Medical, Inc. stock logo
AEMD
Aethlon Medical
$1.42
$1.68
$1.35
$7.20
$3.71M1.888,495 shs2,296 shs
InVivo Therapeutics Holdings Corp. stock logo
NVIV
InVivo Therapeutics
$0.58
$0.22
$2.40
$997K0.658.25 million shs1.89 million shs
Obalon Therapeutics, Inc. stock logo
OBLN
Obalon Therapeutics
$0.17
+6.2%
$4.22
$0.66
$10.77
$1.71M-1.237.68 million shs430,864 shs
Vivos Inc. stock logo
RDGL
Vivos
$0.10
$0.07
$0.04
$0.12
$40.09M1.53721,841 shs501,366 shs
Ra Medical Systems, Inc stock logo
RMED
Ra Medical Systems
$0.73
$0.52
$11.14
$3.19M-0.03197,480 shs77,500 shs
10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Aethlon Medical, Inc. stock logo
AEMD
Aethlon Medical
-0.69%-12.80%-14.37%-27.78%-63.91%
InVivo Therapeutics Holdings Corp. stock logo
NVIV
InVivo Therapeutics
0.00%0.00%0.00%-55.65%-74.14%
Obalon Therapeutics, Inc. stock logo
OBLN
Obalon Therapeutics
+1.55%-1.68%+0.24%-30.92%-94.71%
Vivos Inc. stock logo
RDGL
Vivos
-0.09%+14.57%+45.58%+62.15%+51.87%
Ra Medical Systems, Inc stock logo
RMED
Ra Medical Systems
0.00%0.00%0.00%0.00%-61.18%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Aethlon Medical, Inc. stock logo
AEMD
Aethlon Medical
1.6902 of 5 stars
3.53.00.00.02.50.00.6
InVivo Therapeutics Holdings Corp. stock logo
NVIV
InVivo Therapeutics
N/AN/AN/AN/AN/AN/AN/AN/A
Obalon Therapeutics, Inc. stock logo
OBLN
Obalon Therapeutics
N/AN/AN/AN/AN/AN/AN/AN/A
Vivos Inc. stock logo
RDGL
Vivos
N/AN/AN/AN/AN/AN/AN/AN/A
Ra Medical Systems, Inc stock logo
RMED
Ra Medical Systems
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Aethlon Medical, Inc. stock logo
AEMD
Aethlon Medical
3.00
Buy$10.00606.71% Upside
InVivo Therapeutics Holdings Corp. stock logo
NVIV
InVivo Therapeutics
N/AN/AN/AN/A
Obalon Therapeutics, Inc. stock logo
OBLN
Obalon Therapeutics
N/AN/AN/AN/A
Vivos Inc. stock logo
RDGL
Vivos
N/AN/AN/AN/A
Ra Medical Systems, Inc stock logo
RMED
Ra Medical Systems
N/AN/AN/AN/A

Current Analyst Ratings

Latest OBLN, AEMD, RDGL, NVIV, and RMED Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
3/4/2024
Aethlon Medical, Inc. stock logo
AEMD
Aethlon Medical
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$23.00 ➝ $10.00
(Data available from 4/18/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Aethlon Medical, Inc. stock logo
AEMD
Aethlon Medical
$570K6.50N/AN/A$6.56 per share0.22
InVivo Therapeutics Holdings Corp. stock logo
NVIV
InVivo Therapeutics
N/AN/AN/AN/A$6.48 per shareN/A
Obalon Therapeutics, Inc. stock logo
OBLN
Obalon Therapeutics
$1.59M1.08N/AN/A$0.60 per share0.28
Vivos Inc. stock logo
RDGL
Vivos
$20K2,004.62N/AN/A($0.02) per share-5.16
Ra Medical Systems, Inc stock logo
RMED
Ra Medical Systems
$10K0.00N/AN/A$4.29 per share0.00

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Aethlon Medical, Inc. stock logo
AEMD
Aethlon Medical
-$12.03M-$4.99N/AN/AN/AN/A-106.28%-86.60%6/26/2024 (Estimated)
InVivo Therapeutics Holdings Corp. stock logo
NVIV
InVivo Therapeutics
-$10.49MN/A0.00N/AN/AN/A-75.04%-65.01%N/A
Obalon Therapeutics, Inc. stock logo
OBLN
Obalon Therapeutics
-$12.33MN/AN/AN/A-776.76%-161.38%-83.58%N/A
Vivos Inc. stock logo
RDGL
Vivos
-$2.89MN/A0.00N/A-9,524.89%N/A-180.12%5/2/2024 (Estimated)
Ra Medical Systems, Inc stock logo
RMED
Ra Medical Systems
-$26.86M-$92.36N/AN/AN/AN/A-496.57%-344.49%N/A

Latest OBLN, AEMD, RDGL, NVIV, and RMED Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
3/18/2024Q4 2023
Vivos Inc. stock logo
RDGL
Vivos
N/A-$0.01-$0.01-$0.01N/AN/A
2/14/2024Q3 2024
Aethlon Medical, Inc. stock logo
AEMD
Aethlon Medical
-$1.23-$1.37-$0.14-$1.37N/AN/A

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Aethlon Medical, Inc. stock logo
AEMD
Aethlon Medical
N/AN/AN/AN/AN/A
InVivo Therapeutics Holdings Corp. stock logo
NVIV
InVivo Therapeutics
N/AN/AN/AN/AN/A
Obalon Therapeutics, Inc. stock logo
OBLN
Obalon Therapeutics
N/AN/AN/AN/AN/A
Vivos Inc. stock logo
RDGL
Vivos
N/AN/AN/AN/AN/A
Ra Medical Systems, Inc stock logo
RMED
Ra Medical Systems
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Aethlon Medical, Inc. stock logo
AEMD
Aethlon Medical
N/A
3.93
3.93
InVivo Therapeutics Holdings Corp. stock logo
NVIV
InVivo Therapeutics
N/A
14.30
14.30
Obalon Therapeutics, Inc. stock logo
OBLN
Obalon Therapeutics
N/A
1.86
1.86
Vivos Inc. stock logo
RDGL
Vivos
N/A
6.57
6.57
Ra Medical Systems, Inc stock logo
RMED
Ra Medical Systems
N/A
2.86
2.85

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Aethlon Medical, Inc. stock logo
AEMD
Aethlon Medical
1.99%
InVivo Therapeutics Holdings Corp. stock logo
NVIV
InVivo Therapeutics
13.78%
Obalon Therapeutics, Inc. stock logo
OBLN
Obalon Therapeutics
18.64%
Vivos Inc. stock logo
RDGL
Vivos
N/A
Ra Medical Systems, Inc stock logo
RMED
Ra Medical Systems
11.00%

Insider Ownership

CompanyInsider Ownership
Aethlon Medical, Inc. stock logo
AEMD
Aethlon Medical
4.00%
InVivo Therapeutics Holdings Corp. stock logo
NVIV
InVivo Therapeutics
2.45%
Obalon Therapeutics, Inc. stock logo
OBLN
Obalon Therapeutics
8.10%
Vivos Inc. stock logo
RDGL
Vivos
18.50%
Ra Medical Systems, Inc stock logo
RMED
Ra Medical Systems
18.62%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Aethlon Medical, Inc. stock logo
AEMD
Aethlon Medical
152.62 million2.52 millionOptionable
InVivo Therapeutics Holdings Corp. stock logo
NVIV
InVivo Therapeutics
63.11 million3.03 millionNot Optionable
Obalon Therapeutics, Inc. stock logo
OBLN
Obalon Therapeutics
210.02 millionN/ANot Optionable
Vivos Inc. stock logo
RDGL
Vivos
1388.87 million316.93 millionNot Optionable
Ra Medical Systems, Inc stock logo
RMED
Ra Medical Systems
145.37 million4.37 millionNot Optionable

OBLN, AEMD, RDGL, NVIV, and RMED Headlines

SourceHeadline
Dietary Interventions Reduce CVD Risk in RA and SpADietary Interventions Reduce CVD Risk in RA and SpA
ajmc.com - March 8 at 7:57 PM
Alert1 Medical Alert System Review: What Experts Say (2024)Alert1 Medical Alert System Review: What Experts Say (2024)
forbes.com - February 20 at 9:27 PM
Ra Medical Systems Inc.Ra Medical Systems Inc.
thestreet.com - February 15 at 10:42 AM
Catheter Precision Inc (VTAK)Catheter Precision Inc (VTAK)
investing.com - February 11 at 11:09 PM
VTAK Catheter Precision, Inc.VTAK Catheter Precision, Inc.
seekingalpha.com - January 19 at 6:41 PM
What Is The Life Expectancy Of Rheumatoid Arthritis? A Review By DoctorsWhat Is The Life Expectancy Of Rheumatoid Arthritis? A Review By Doctors
msn.com - January 7 at 11:58 PM
Catheter Precision Receives Notice from NYSE American Regarding Late Filing of Quarterly Report on Form 10-QCatheter Precision Receives Notice from NYSE American Regarding Late Filing of Quarterly Report on Form 10-Q
finance.yahoo.com - August 25 at 6:53 PM
Reminder: Ra Medical Systems Announces Name and Ticker Symbol ChangesReminder: Ra Medical Systems Announces Name and Ticker Symbol Changes
finance.yahoo.com - August 17 at 9:15 AM
Ra Medical Systems, Inc.: Ra Medical Systems Announces Allowance of New Closure Device PatentRa Medical Systems, Inc.: Ra Medical Systems Announces Allowance of New Closure Device Patent
finanznachrichten.de - August 16 at 6:14 PM
Ra Medical Systems Announces Milestone Achievement for Electrophysiology DivisionRa Medical Systems Announces Milestone Achievement for Electrophysiology Division
finance.yahoo.com - August 7 at 12:14 PM
Ra Medical Systems, Inc.: Ra Medical Systems Announces Proposed Name and Ticker Symbol ChangesRa Medical Systems, Inc.: Ra Medical Systems Announces Proposed Name and Ticker Symbol Changes
finanznachrichten.de - August 2 at 8:13 AM
Ra Medical says demand is rising for its non-invasive electrophysiology mapping systemRa Medical says demand is rising for its non-invasive electrophysiology mapping system
massdevice.com - July 24 at 5:15 PM
Ra Medical Systems, Inc.: Ra Medical Systems Electrophysiology Division Has Increased Demand for its Non-invasive Mapping SystemRa Medical Systems, Inc.: Ra Medical System's Electrophysiology Division Has Increased Demand for its Non-invasive Mapping System
finanznachrichten.de - July 24 at 12:14 PM
Ra Medical System’s Electrophysiology Division Has Increased Demand for its Non-invasive Mapping SystemRa Medical System’s Electrophysiology Division Has Increased Demand for its Non-invasive Mapping System
finance.yahoo.com - July 24 at 12:14 PM
Ra Medical Systems, Inc.: RMEDs LockeT Device Utilized in Structural Heart ProceduresRa Medical Systems, Inc.: RMED's LockeT Device Utilized in Structural Heart Procedures
finanznachrichten.de - July 6 at 10:17 AM
RMEDs LockeT Device Utilized in Structural Heart ProceduresRMED's LockeT Device Utilized in Structural Heart Procedures
finance.yahoo.com - July 6 at 10:17 AM
Investing in Ra Medical Systems Inc (RMED): What You Must KnowInvesting in Ra Medical Systems Inc (RMED): What You Must Know
knoxdaily.com - July 5 at 6:18 PM
Ra Medical Systems, Inc.: RMEDs Electrophysiology Division Submits Data for CE Mark on LockeT Expects to Receive CE Mark in Third Quarter, 2023Ra Medical Systems, Inc.: RMED's Electrophysiology Division Submits Data for CE Mark on LockeT Expects to Receive CE Mark in Third Quarter, 2023
finanznachrichten.de - June 28 at 9:07 AM
RMEDs Electrophysiology Division Submits Data for CE Mark on LockeT Expects to Receive CE Mark in Third Quarter, 2023RMED's Electrophysiology Division Submits Data for CE Mark on LockeT Expects to Receive CE Mark in Third Quarter, 2023
finance.yahoo.com - June 28 at 9:07 AM
Ra Medical Systems, Inc.: Ra Medicals Electrophysiology Division Announces First Hospital to Complete 100 Procedures Using the VIVO SystemRa Medical Systems, Inc.: Ra Medical's Electrophysiology Division Announces First Hospital to Complete 100 Procedures Using the VIVO System
finanznachrichten.de - June 12 at 4:10 PM
Ra Medical’s Electrophysiology Division Announces First Hospital to Complete 100 Procedures Using the VIVO SystemRa Medical’s Electrophysiology Division Announces First Hospital to Complete 100 Procedures Using the VIVO System
finance.yahoo.com - June 12 at 4:10 PM
Medical Device Co. Completes Merger in Q1/23Medical Device Co. Completes Merger in Q1/23
investorideas.com - June 9 at 9:35 PM
Ra Medical Systems reports Q1 resultsRa Medical Systems reports Q1 results
msn.com - June 5 at 10:34 AM
Ra Medical Systems, Inc.: Ra Medical Systems Announces First Quarter ResultsRa Medical Systems, Inc.: Ra Medical Systems Announces First Quarter Results
finanznachrichten.de - June 2 at 9:16 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Aethlon Medical logo

Aethlon Medical

NASDAQ:AEMD
Aethlon Medical, Inc., a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Aethlon Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses from the human circulatory system. The company was founded in 1999 and is based in San Diego, California.
InVivo Therapeutics logo

InVivo Therapeutics

NASDAQ:NVIV
InVivo Therapeutics Holdings Corp. operates as a research and clinical-stage biomaterials and biotechnology company in the United States. The company engages in developing and commercializing biopolymer scaffolding devices for the treatment of spinal cord injuries (SCI). It is developing a Neuro-Spinal Scaffold implant comprise of biocompatible and bioresorbable polymers, which includes Poly lactic-co-glycolic acid, a polymer which is widely used in resorbable sutures and provides the biocompatible support for Neuro-Spinal Scaffold implant; and Poly-L-Lysine, a positively charged polymer used to coat surfaces to promote cellular attachment. The company was incorporated in 2003 and is headquartered in Cambridge, Massachusetts. On February 1, 2024, InVivo Therapeutics Holdings Corp. filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware. It is in joint administration with InVivo Therapeutics Corporation.
Obalon Therapeutics logo

Obalon Therapeutics

NASDAQ:OBLN
Obalon Therapeutics, Inc., a vertically integrated medical device company, focuses on developing and commercializing medical devices to treat people with obesity. The company offers the Obalon Balloon System designed to provide weight loss in patients with obesity. Its Obalon Balloon System comprises of a swallowable capsule that contains an inflatable balloon attached to a microcatheter; the Obalon Navigation System console, which is a combination of hardware and software used to track and display the location of the balloon during placement; the Obalon Touch Inflation Dispenser, which is a semi-automated, hand-held inflation device used to inflate the balloon once it is placed; and a disposable canister filled with mixture of gas. Obalon Therapeutics, Inc. was incorporated in 2008 and is headquartered in Carlsbad, California.
Vivos logo

Vivos

OTCMKTS:RDGL
Vivos Inc., a radiation oncology medical device company, develops brachytherapy devices for the treatment of non-resectable tumors in the United States and internationally. It develops yttrium-90 based RadioGel device, an injectable particle-gel for brachytherapy radiation treatment of cancerous tumors in people and animals; and IsoPet for the treatment of solid tumors in animals. The company was formerly known as Advanced Medical Isotope Corporation and changed its name to Vivos Inc. in December 2017. Vivos Inc. was incorporated in 1994 and is headquartered in Richland, Washington.
Ra Medical Systems logo

Ra Medical Systems

NYSE:RMED
Ra Medical Systems, Inc develops and delivers electrophysiology products to provide patients, hospitals, and physicians with technologies and solutions to improve the lives of patients with cardiac arrhythmias in the United States. The company's lead product is View into Ventricular Onset System, a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. It also provides LockeT, a suture retention device; and Amigo Remote Catheter System, a robotic arm that serves as a catheter control device. Ra Medical Systems, Inc is based in Fort Mill, South Carolina.